-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
-
-
-
-
-
-
-
From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
-
-
-
-
-
-
-
HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute
-
-
-
-
-
-
-
NRx Pharmaceuticals (NRXP) and HOPE Sign Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
-
-
-
-
-
-
-
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
-
-
-
-
-
-
-
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel
-
1,157,579 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

